Enhancers are cis-regulatory elements which control the expression of genes in a defined spatiotemporal pattern, enabling the normal morphogenesis of organs and structures during embryogenesis. Enhancers control their target genes independently of their orientation or distance through chromosomal looping and are thought to evolve through various mutational mechanisms (1). A critical biological process that leads to the acquisition of new gene expression domains as well as pathological outcomes is termed "enhancer adoption," whereby a gene is regulated by an enhancer that is not normally its own (2). Enhancer adoption can derive from the insertion of transposable elements (TEs) with regulatory capacities or genomic structural variants (SVs). In particular, many studies have demonstrated the importance of SVs, including deletions, inversions, duplications, and translocations, with regard to 3D genome organization, gene regulation, and disease (3-5). Recent advances in genome engineering and in sequencing technologies have contributed to a deeper understanding of the molecular mechanisms behind genomic rearrangements and their role in evolution and pathology. Therefore, researchers have seized the opportunity to reinterpret old mouse alleles obtained by spontaneous mutations like X-irradiation-induced phocomelia, Hemimelic extra toes (Hx), Ulnaless, and so on, in the light of modern molecular tools (6) (7) (8) . In PNAS, Mouri et al. (10) set out to reanalyze a mouse mutant with syndactyly and interdigital webbing, known as Hammer toe (Hm), first described in 1964 (9) . The authors found that a genomic insertion of an interdigital regulatory region in the vicinity of the gene Sonic hedgehog (Shh) results in its ectopic expression and the Hm phenotype. The authors use chromatin technologies and CRISPR/Cas9 genetic engineering to dissect the regulatory function of the inserted region and to reverse the Hm phenotype. Their results bring an important conceptual framework to the interpretation of diseases caused by large genomic insertions (10) .
Insertions are SVs that occur when DNA chromosomal segments integrate into new genomic locations through natural (DNA recombination, repair, or replication) or induced (X-irradiation) mutational mechanisms. As this type of SVs changes the number of base pairs in the genome, they can be referred to as copy number or unbalanced variants. Large insertions can be due to TE insertions or more complex rearrangements, known as insertional translocations. TEs are DNA sequences that have the ability to move themselves to a different genomic location. They are divided into two classes: the DNA transposons which mobilize in a "cut-and-paste" mechanism and the retrotransposons that sequentially transcribe and reverse-transcribe themselves before "jumping" in another locus. Retrotransposons include, among others, LINEs (long interspersed nuclear elements), which comprise almost 20% of the human genome and can be "hotspots" of structural rearrangements (11) (12) (13) . In contrast, insertional translocations are fragments of a chromosome, that can vary in size, transferred into a nonhomologous genomic region (13) . In humans, studies have demonstrated that de novo insertions might originate from parental balanced translocations (14, 15) or they can include multiple segments in either orientation (16, 17) . However, it remains a challenge to identify them and even more to reveal their origin. Array CGH is commonly used to detect copy number variations in patients but is not sufficient to find and map the location of insertions. Complementary approaches, such as inverse PCR experiments, chromosome banding for larger rearrangements, and FISH are additionally used. More recently, long read sequencing technologies and different computational approaches provided another efficient way to uncover insertions (18) . In Mouri et al. (10) , the authors characterize a 150-kb de novo genomic insertion in a preexisting LINE at the Shh locus at chromosome 5. Although the mechanism underlying its generation remains unknown, the authors functionally analyze its effect on Shh transcription and digit development.
Despite the high impact of structural variations on genome evolution and disease there have been a limited number of functional studies focusing on their biological outcome. On the one hand, pathological SVs can affect the coding part of the genome by altering the dosage of genes or by disrupting their normal sequences (19) . On the other hand, SVs can affect the noncoding part of the genome, which is critical to ensure normal gene expression, for example by altering enhancer dosage (20) . Alternatively, several studies have shown that SVs might lead to loss of insulation between chromatin domains, called topologically associating domains (TADs), which normally constrain the pairing of enhancers and promoters (21) . Indeed, these SVs were shown to enable enhancers and promoters from neighboring TADs to interact, leading to gene misexpression and disease (3-5). Therefore, genomic rearrangements have been shown to either affect the gene content, the cis-regulatory information around it, or the TAD structure of loci. In the case of the Hm mice, the insertion was found in a gene desert within the Shh TAD. First, Mouri et al. (10) narrowed down the size of the insertion using classical linkage analysis. After analyzing numerous recombinant mice they showed that the Hm inserted sequence (HIS) acts in cis on Shh. Next, by using inverse PCR they were able to locate the origin of the fragment at chromosome 14. Although the deletion of the original HIS fragment on chromosome 14 does not result in obvious limb phenotype, the authors showed, using reporter assays, that it contains limb enhancer activity. As a result of the HIS within the Shh regulatory landscape Shh becomes ectopically expressed in the interdigital space (Fig. 1) . This ectopic expression induces bone morphogenetic protein signaling and loss of apoptosis in the interdigital space, ultimately leading to interdigital webbing and syndactyly phenotype. Moreover, the authors could demonstrate that this 150-kb integration did not perturb the early regulatory activity of the endogenous ZRS/MFCS1 limb enhancer.
CRISPR/Cas9 has revolutionized the field of functional genomics by providing researchers with tools enabling fast and efficient genome editing (22) . The use of CRISPR/Cas9 technology was in this study critical for the characterization of the Hm mice. Specifically, Mouri et al. (10) identified first the HIS subregions responsible for its regulatory activity using a chromatin accessibility assay and assessed their function in reporter experiments. Next, to test if the Hm phenotype can be rescued they used the CRISPR/Cas9 technology and deleted the HIS from the Hm genome. As a result, the limb phenotype was reversed and the animals were indistinguishable from wild-type animals. In parallel, the authors obtained a CRISPR/Cas9-mediated inversion of HIS, which resulted in stronger Shh overexpression. The Hm-inv mice, as they were named, exhibited swollen soles and cleft palate leading to neonatal lethality, in contrast to Hm mice, which are fully viable. The authors argue that the observed phenotype is likely due to an orientation-dependent transcription factor. CTCF is a factor known for facilitating enhancer-promoter communication through DNA looping. Based on the current model, looping can be achieved between two convergent CTCF sites mediated by the cohesin ring-like protein (23) . However, there were no CTCF motifs found at this insertion site (10) . Alternatively, the relative enhancer proximity to the insertion borders, which differs in both alleles, might influence the strength of chromatin interactions between the enhancers and Shh and thereby result in variable overexpression levels. Generally, this surprising result remains for further future investigation.
Finally, the discovery of this insertion-based enhancer adoption mechanism provides a new framework for the understanding of pathomechanisms underlying genomic insertions. It further urges the need to develop efficient tools to detect and characterize pathological insertions genome-wide in human patients. Fig. 1 . The pathomechanism of the Hm mouse mutation. The Hm mice are characterized by a genomic insertion (HIS), originating from chromosome 14, between Shh and its limb enhancer ZRS/MFCS1 (orange oval). HIS contains enhancer elements (green ovals) that can drive Shh expression ectopically at the interdigital space of the limb at embryonic stage E13.5 (green staining in the limb above the HIS region). Shh misexpression (purple staining in limbs at E13.5) leads to decreased interdigital cell death, soft tissue syndactyly, and interdigital webbing in adults. Note that the expression of Shh in the posterior part of the limb at embryonic stage E11.5 (purple staining in limbs), which is controlled by the ZRS/MFCS1 enhancer (orange staining in limb above the ZRS/MFCS1), remains unchanged between wild-type and Hm mice.
Shh Lmbr1

ZRS/MFCS1
